Načítá se...
Urate-Lowering Therapy in Moderate to Severe Chronic Kidney Disease
CONTEXT: Hyperuricemia is an independent risk factor for progression of kidney disease. OBJECTIVE: To determine whether lowering serum uric acid level (sUA) to below 6 mg/dL (target) improves mild to moderate chronic kidney disease (CKD) and whether CKD stage influences the benefit of lowering sUA t...
Uloženo v:
| Vydáno v: | Perm J |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Permanente Journal
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6131097/ https://ncbi.nlm.nih.gov/pubmed/30201087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/17-142 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|